263 related articles for article (PubMed ID: 26148858)
1. Nanosecond pulsed electric field inhibits proliferation and induces apoptosis in human osteosarcoma.
Miao X; Yin S; Shao Z; Zhang Y; Chen X
J Orthop Surg Res; 2015 Jul; 10():104. PubMed ID: 26148858
[TBL] [Abstract][Full Text] [Related]
2. Long term survival of mice with hepatocellular carcinoma after pulse power ablation with nanosecond pulsed electric fields.
Chen X; Zhuang J; Kolb JF; Schoenbach KH; Beebe SJ
Technol Cancer Res Treat; 2012 Feb; 11(1):83-93. PubMed ID: 22181334
[TBL] [Abstract][Full Text] [Related]
3. Nano-pulse stimulation (NPS) ablate tumors and inhibit lung metastasis on both canine spontaneous osteosarcoma and murine transplanted hepatocellular carcinoma with high metastatic potential.
Chen X; Chen Y; Jiang J; Wu L; Yin S; Miao X; Swanson RJ; Zheng S
Oncotarget; 2017 Jul; 8(27):44032-44039. PubMed ID: 28476039
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: blockade of the vicious cycle between tumor cell proliferation and bone resorption.
Lamoureux F; Richard P; Wittrant Y; Battaglia S; Pilet P; Trichet V; Blanchard F; Gouin F; Pitard B; Heymann D; Redini F
Cancer Res; 2007 Aug; 67(15):7308-18. PubMed ID: 17671200
[TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha.
Wada N; Maeda H; Yoshimine Y; Akamine A
Bone; 2004 Sep; 35(3):629-35. PubMed ID: 15336598
[TBL] [Abstract][Full Text] [Related]
6. Glycosaminoglycans as potential regulators of osteoprotegerin therapeutic activity in osteosarcoma.
Lamoureux F; Picarda G; Garrigue-Antar L; Baud'huin M; Trichet V; Vidal A; Miot-Noirault E; Pitard B; Heymann D; Rédini F
Cancer Res; 2009 Jan; 69(2):526-36. PubMed ID: 19147566
[TBL] [Abstract][Full Text] [Related]
7. Osteoprotegerin activates osteosarcoma cells that co-express RANK and RANKL.
Marley K; Bracha S; Seguin B
Exp Cell Res; 2015 Oct; 338(1):32-8. PubMed ID: 26254896
[TBL] [Abstract][Full Text] [Related]
8. [The effects of 17 beta-estradiol on the expression of osteoprotegerin, the ligand of osteoprotegerin and related cytokines in osteosarcoma MG63 cells].
Su X; Liao EY; Peng J; Wu XP
Zhonghua Nei Ke Za Zhi; 2003 Nov; 42(11):800-3. PubMed ID: 14636471
[TBL] [Abstract][Full Text] [Related]
9. Silencing of Kv1.5 Gene Inhibits Proliferation and Induces Apoptosis of Osteosarcoma Cells.
Wu J; Chen Z; Liu Q; Zeng W; Wu X; Lin B
Int J Mol Sci; 2015 Nov; 16(11):26914-26. PubMed ID: 26569226
[TBL] [Abstract][Full Text] [Related]
10. Effects of intermedin on proliferation, apoptosis and the expression of OPG/RANKL/M-CSF in the MC3T3-E1 osteoblast cell line.
Ren H; Ren H; Li X; Yu D; Mu S; Chen Z; Fu Q
Mol Med Rep; 2015 Nov; 12(5):6711-7. PubMed ID: 26398911
[TBL] [Abstract][Full Text] [Related]
11. Effect of hydrogen sulphide on the expression of osteoprotegerin and receptor activator of NF-κB ligand in human periodontal ligament cells induced by tension-force stimulation.
Liao C; Hua Y
Arch Oral Biol; 2013 Dec; 58(12):1784-90. PubMed ID: 24200305
[TBL] [Abstract][Full Text] [Related]
12. Nanosecond pulsed electric field (nsPEF) disrupts the structure and metabolism of human Echinococcus granulosus protoscolex in vitro with a dose effect.
Zhang R; Aji T; Shao Y; Jiang T; Yang L; Lv W; Chen Y; Chen X; Wen H
Parasitol Res; 2017 Apr; 116(4):1345-1351. PubMed ID: 28236173
[TBL] [Abstract][Full Text] [Related]
13. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E
Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of the receptor activator of NF-kappaB ligand and osteoprotegerin production influence the apoptosis of multiple myeloma patients' bone marrow stromal cells co-cultured with myeloma cells.
Zdzisińska B; Bojarska-Junak A; Walter-Croneck A; Kandefer-Szerszeń M
Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):153-63. PubMed ID: 20157786
[TBL] [Abstract][Full Text] [Related]
15. In vitro effects of erythromycin on RANKL and nuclear factor-kappa B by human TNF-alpha stimulated Jurkat cells.
Wu L; Lin JH; Bao K; Li PF; Zhang WG
Int Immunopharmacol; 2009 Aug; 9(9):1105-9. PubMed ID: 19500694
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis.
Evdokiou A; Bouralexis S; Atkins GJ; Chai F; Hay S; Clayer M; Findlay DM
Int J Cancer; 2002 Jun; 99(4):491-504. PubMed ID: 11992538
[TBL] [Abstract][Full Text] [Related]
17. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous papilloma and squamous cell carcinoma therapy utilizing nanosecond pulsed electric fields (nsPEF).
Yin D; Yang WG; Weissberg J; Goff CB; Chen W; Kuwayama Y; Leiter A; Xing H; Meixel A; Gaut D; Kirkbir F; Sawcer D; Vernier PT; Said JW; Gundersen MA; Koeffler HP
PLoS One; 2012; 7(8):e43891. PubMed ID: 22937117
[TBL] [Abstract][Full Text] [Related]
19. Environmental temperature affects physiology and survival of nanosecond pulsed electric field-treated cells.
Yin S; Miao X; Zhang X; Chen X; Wen H
J Cell Physiol; 2018 Feb; 233(2):1179-1190. PubMed ID: 28467607
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonates inhibit osteosarcoma-mediated osteolysis via attenuation of tumor expression of MCP-1 and RANKL.
Ohba T; Cole HA; Cates JM; Slosky DA; Haro H; Ando T; Schwartz HS; Schoenecker JG
J Bone Miner Res; 2014 Jun; 29(6):1431-45. PubMed ID: 24443409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
